NCT03155802 Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines Status UNKNOWN Phase N/A
NCT03151057 Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies Status TERMINATED Phase PHASE1
NCT03135028 Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults Status TERMINATED Phase PHASE1
NCT03134222 Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) Status COMPLETED Phase PHASE2
NCT03133221 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT03121235 PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome. Status COMPLETED Phase N/A
NCT03120494 Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B Status UNKNOWN Phase PHASE4
NCT03118843 Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study Status COMPLETED Phase PHASE3
NCT03116932 Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part A Status UNKNOWN Phase N/A
NCT03110380 Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed Status COMPLETED Phase PHASE3
NCT03100942 Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome Status COMPLETED Phase PHASE2
NCT03078153 Effect of Social Media Support and Financial Incentives on PrEP Adherence Status COMPLETED Phase NA
NCT03077412 Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease Status COMPLETED Phase PHASE2
NCT03074786 Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH) Status WITHDRAWN Phase PHASE2
NCT03074331 Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection Status COMPLETED Phase PHASE3
NCT03060447 Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers Status COMPLETED Phase PHASE1
NCT03053063 Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Status TERMINATED Phase PHASE3